Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment

Novel silyl cyanocinnamic acid derivatives have been synthesized and evaluated as potential anticancer agents. In vitro studies reveal that lead derivatives 2a and 2b have enhanced cancer cell proliferation inhibition properties when compared to the parent monocarboxylate transporter (MCT) inhibitor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Nelson, Grady L., Ronayne, Conor T., Solano, Lucas N., Jonnalagadda, Sravan K., Jonnalagadda, Shirisha, Rumbley, Jon, Holy, Jon, Rose-Hellekant, Teresa, Drewes, Lester R., Mereddy, Venkatram R.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6892925/
https://ncbi.nlm.nih.gov/pubmed/31797891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-54709-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados